BMO Capital Markets has issued a detailed sector note recapping the recent drama in the UK chemical industry, highlighting a period of acute pressure for speciality chemical manufacturers. The analyst commentary points to a combination of weak end-market demand, elevated energy costs, and destocking by customers as key factors behind the sector's struggles. The note underscores how several mid-cap chemical firms have seen their share prices slide sharply over recent quarters, underperforming the broader FTSE 250 index.
The FTSE 250, which contains a number of chemical and industrial names, closed at 19,842.56 on Tuesday, down 0.4 per cent on the session. The broader FTSE 100 fell 0.3 per cent to 7,614.23. Among the notable movers in the chemical space, shares of Synthomer PLC and Johnson Matthey have faced particular headwinds, with both companies issuing profit warnings in recent months. BMO's analysis suggests that the sector's recovery may be delayed until a clearer upturn in global industrial production materialises.
Context for UK investors is important: the chemical sector is a significant component of several popular UK equity income and growth funds. Pension holders with exposure to the FTSE 250, either through direct tracker funds or defined contribution schemes, have felt the impact of this downturn. The sector's struggles also reflect wider challenges in UK manufacturing, where high energy prices—driven by geopolitical tensions and domestic policy—continue to squeeze margins.
Analysts at BMO noted that while some subsectors, such as agrochemicals, have shown relative resilience, the speciality chemicals segment faces a more uncertain outlook. They pointed to ongoing destocking across supply chains, particularly in Europe, as a drag on volumes. The note also highlighted that chemical companies are delaying capital expenditure and reducing headcount in response to the weak environment, actions that may support margins in the near term but could hinder long-term growth.
For UK investors, the BMO note serves as a reminder of the cyclical nature of the chemical industry and the importance of diversification within industrial holdings. The FTSE 250's chemical constituents now trade at historically low valuation multiples, but analysts caution that a catalyst for recovery—such as a sustained drop in energy prices or a rebound in European manufacturing—has yet to emerge. Source: BMO Capital Markets.